Clinical Advisory Committee

Page last updated: 14 November 2019

The BreastScreen Australia Clinical Advisory Committee (CAC) provides expert advice to BreastScreen Australia Program Managers about clinical issues to enhance the delivery of nationally consistent, evidence-based, high quality breast screening services to improve health outcomes for eligible women.

The CAC:

  • Reviews and advises of clinical evidence in relation to the BreastScreen Australia program.
  • Provides advice on national clinical policies and procedures, and new and emerging technologies.
  • Provides timely advice about clinical issues and risks.
  • Advice is provided within the context of current evidence-based best practice, and aligned with relevant college policies, guidelines and legislation.

The BreastScreen Australia Program Management Group appoints the CAC Chair, members and their proxies. CAC comprises:

  • Radiologists, with experience in breast screening (two)
  • Breast Physician
  • Breast Surgeon
  • Pathologists, with experience in breast screening (two)
  • Radiographer, with experience in breast screening
  • Program Management representative
  • Commonwealth representative
  • Other specialists or expertise may be co-opted as needed.

BreastScreen Australia Clinical Advisory Committee advice

CAC advice is intended as guidance for the BreastScreen Australia program, and is not mandatory. Program managers have endorsed the advice on the following topics:

In this section